$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Time to market and market feedback of tenofovir alafenamide fumarate tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
Analysis of the recommended treatment course for patients with psoriasis taking decavatinib
2026-02-01 22:25:32
Check Details
Potential risks caused by long-term use of Apremilast (Otelor)
2026-02-01 22:25:32
Check Details
Safety and risk assessment of long-term use of Valganciclovir
2026-02-01 22:25:32
Check Details
How long should Osimertinib (Tarisso) be taken for the best effect and treatment schedule?
2026-02-01 22:25:32
Check Details
If eltrombopag (Revlan) is ineffective, can the drug be discontinued directly and safety guidance
2026-02-01 22:25:32
Check Details
How to buy Romiplostim from cheaper, regular and reliable channels
2026-02-01 22:25:32
Check Details
The efficacy, role and clinical use evaluation of Midostaurin
2026-02-01 22:25:32
Check Details
Cabergoline generic drug price and domestic purchase reference
2026-02-01 22:25:32
Check Details
Whether Momelotinib requires long-term use and long-term safety assessment
2026-02-01 22:25:32
Check Details
Can Bikeren Prenol Tablets (Bituvi) be stopped suddenly and the possible risks caused by stopping the medicine?
2026-02-01 22:25:32
Check Details
The best time to take decavatinib and daily dosage schedule
2026-02-01 22:25:32
Check Details
1
2
...
2338
2339
2340
2341
2342
2343
2344
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
2
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
3
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
4
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
5
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
6
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
7
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
8
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
9
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
10
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
11
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
12
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor